Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-24T03:11:23.797Z Has data issue: false hasContentIssue false

Incipient Neuroleptic Malignant Syndrome?

Published online by Cambridge University Press:  03 January 2018

V. R. Velamoor*
Affiliation:
Victoria Hospital, London, Ontario and University of Western Ontario, London, Ontario N6A 3K7
M. L. D. Fernando
Affiliation:
University of Western Ontario and Director, Essex County, St Thomas Psychiatric Hospital, St Thomas, Ontario N5P 3V9
P. Williamson
Affiliation:
University of Western Ontario, Head, Active Treatment Clinic, London Psychiatric Hospital, 850 Highbury Avenue, London, Ontario N6A 4H1, Canada
*
Correspondence

Abstract

Recognising confusion as an antecedent to NMS may help abort the full-blown syndrome. Two such cases are reported, along with a third.

Type
Brief Reports
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 15871590.Google Scholar
Adityanjee, , Singh, S. & Singh, G. (1988) Spectrum concept of neuroleptic malignant syndrome. British Journal of Psychiatry, 153, 107111.CrossRefGoogle ScholarPubMed
Allan, R. N. & White, H. C. (1972) Side-effects of parenteral long-acting phenothiazines. British Medical Journal, i, 221.CrossRefGoogle Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 7983.Google Scholar
Castillo, E., Rubin, R. T. & Holsboer-Trachsler, E. (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324328.Google ScholarPubMed
Cohen, W. & Cohen, N. (1974) Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association, 230, 12831287.Google Scholar
Destee, A., Montagne, B. & Rousseaux, M. (1980) Incidents et accidents des neuroleptiques (110 hospitalizations en neurologie). Lille Medicin, 25, 291295.Google Scholar
Gelenberg, A. J., Bellinghausen, B., Wojcik, J., et al (1988) A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. American Journal of Psychiatry, 145, 517518.Google Scholar
Goulon, M., Rohan-Chabot, P., De Elkhaart, D., et al (1983) Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Neurology, 33, 516518.Google ScholarPubMed
Hashimoto, F., Sherman, C. B. & Jeffery, W. H. (1984) Neuroleptic malignant syndrome and dopaminergic blockade. Archives of Internal Medicine, 144, 629630.Google Scholar
Lazarus, A. (1986) The neuroleptic malignant syndrome: a review. Canadian Journal of Psychiatry, 31, 670674.Google Scholar
Pope, H. G., Keck, P. E. & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 12271233.Google Scholar
Prakash, R., Kelwala, S. & Ban, T. (1982) Neurotoxicity with combined administration of lithium and a neuroleptic. Comprehensive Psychiatry, 23, 567570.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica, 73, 337347.Google Scholar
Van Putten, T., Beckson, M. & Marder, S. R. (1988) The neuroleptic malignant syndrome manifested as a prolonged confusional state. Journal of Clinical Psychopharmacology, 8, 229230.CrossRefGoogle ScholarPubMed
Weinberg, S. E. & Twerski, R. S. (1983) Neuroleptic malignant syndrome. Anesthesia and Analgesia, 62, 848850.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.